High Levels of Epstein–Barr Virus Nuclear Antigen-1-Specific Antibodies and Infectious Mononucleosis Act Both Independently and Synergistically to Increase Multiple Sclerosis Risk-Reference-Cited by-同舟云学术

High Levels of Epstein–Barr Virus Nuclear Antigen-1-Specific Antibodies and Infectious Mononucleosis Act Both Independently and Synergistically to Increase Multiple Sclerosis Risk

Published:2020-01-24 Issue: Volume:10 Page:
ISSN:1664-2295
Container-title:Frontiers in Neurology
language:
Short-container-title:Front. Neurol.

Author:

Hedström Anna Karin,Huang Jesse,Michel Angelica,Butt Julia,Brenner Nicole,Hillert Jan,Waterboer Tim,Kockum Ingrid,Olsson Tomas,Alfredsson Lars

Funder

Medicinska Forskningsrådet

Forskningsrådet om Hälsa, Arbetsliv och Väfärd

Horizon 2020

Hjärnfonden

Svenska Sällskapet för Medicinsk Forskning

Publisher

Frontiers Media SA

Subject

Neurology (clinical),Neurology

Reference32 articles.

1. Class II HLA interactions modulate genetic risk for multiple sclerosis;Moutsianas;Nat Genet.,2015

2. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis;Sawcer;Nature.,2011

3. Analysis of immune-related loci identifies 48 new susceptibility variants of multiple sclerosis;Beecham;Nat Genet.,2013

4. Primary infection with the Epstein–Barr virus and risk of multiple sclerosis;Levin;Ann Neurol.,2010

5. An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis;Handel;PLoS ONE.,2010

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhanced and cross-reactive in vitro memory B cell response against Epstein-Barr virus nuclear antigen 1 in multiple sclerosis;Frontiers in Immunology;2024-08-27

2. Heightened Epstein-Barr virus immunity and potential cross-reactivities in multiple sclerosis;PLOS Pathogens;2024-06-06

3. Ocrelizumab B cell depletion has no effect on HERV RNA expression in PBMC in MS patients;Multiple Sclerosis and Related Disorders;2024-06

4. Genetics of immune response to Epstein-Barr virus: prospects for multiple sclerosis pathogenesis;Brain;2024-04-17

5. Risk of multiple sclerosis in individuals with infectious mononucleosis: a national population-based cohort study using hospital records in England, 2003–2023;Multiple Sclerosis Journal;2024-03-21